The UK Fibroscan Market is instrumental in the ongoing efforts to address the rising burden of chronic liver disease. As the number of patients requiring long-term monitoring for conditions like NAFLD and viral hepatitis increases, the healthcare system faces the challenge of providing efficient and accurate diagnostic services. Fibroscan technology has become a vital part of the solution,...